GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) » Definitions » Debt-to-Equity

QuiaPEG Pharmaceuticals Holding AB (OSTO:QUIA) Debt-to-Equity : 0.00 (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QuiaPEG Pharmaceuticals Holding AB Debt-to-Equity?

QuiaPEG Pharmaceuticals Holding AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr0.00 Mil. QuiaPEG Pharmaceuticals Holding AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr0.00 Mil. QuiaPEG Pharmaceuticals Holding AB's Total Stockholders Equity for the quarter that ended in Jun. 2024 was kr34.68 Mil. QuiaPEG Pharmaceuticals Holding AB's debt to equity for the quarter that ended in Jun. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity or its related term are showing as below:

OSTO:QUIA' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.02   Med: 1.28   Max: 773.87
Current: 0.59

During the past 13 years, the highest Debt-to-Equity Ratio of QuiaPEG Pharmaceuticals Holding AB was 773.87. The lowest was -2.02. And the median was 1.28.

OSTO:QUIA's Debt-to-Equity is ranked worse than
78.83% of 1025 companies
in the Biotechnology industry
Industry Median: 0.14 vs OSTO:QUIA: 0.59

QuiaPEG Pharmaceuticals Holding AB Debt-to-Equity Historical Data

The historical data trend for QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuiaPEG Pharmaceuticals Holding AB Debt-to-Equity Chart

QuiaPEG Pharmaceuticals Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.02 80.99 773.87 6.44 1.35

QuiaPEG Pharmaceuticals Holding AB Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 6.44 1.34 1.35 -

Competitive Comparison of QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity

For the Biotechnology subindustry, QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity falls into.



QuiaPEG Pharmaceuticals Holding AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

QuiaPEG Pharmaceuticals Holding AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

QuiaPEG Pharmaceuticals Holding AB's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QuiaPEG Pharmaceuticals Holding AB  (OSTO:QUIA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


QuiaPEG Pharmaceuticals Holding AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of QuiaPEG Pharmaceuticals Holding AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


QuiaPEG Pharmaceuticals Holding AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala Business Park, Uppsala, SWE, 754 54
QuiaPEG Pharmaceuticals Holding AB is a biotech company. It develops biopharmaceuticals based PEGylation technologies platform, which is applicable to proteins, peptides, and small molecules or oligonucleotides.

QuiaPEG Pharmaceuticals Holding AB Headlines

No Headlines